4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-25-015701
Co-Chief Executive Officer acquired 36,310 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Klee Justin B. Co-Chief Executive Officer | 2025-02-05 | Option exercise | +36,310 | $1.57 | $57,007 | 3,201,243 | D |
| Derivatives | |||||||
| Klee Justin B. Co-Chief Executive Officer | 2025-02-05 | Option exercise · Stock Option (right to buy) | −36,310 | 0 | D | ||
Loading xslF345X05/ownership.xml…